Aminoglycoside Nephrotoxicity

Aminoglycoside nephrotoxicity is kidney damage caused by aminoglycoside antibiotics, such as gentamicin, which can accumulate in kidney tissue and impair its function, particularly with prolonged use or high doses.

It results from the direct toxic effect of aminoglycoside antibiotics on kidney tubule cells, with risk increased by higher doses, longer treatment duration, dehydration, and pre-existing kidney impairment.

Symptoms can be subtle initially, often identified through blood tests showing rising creatinine, and may include reduced urine output or general symptoms of declining kidney function in more significant cases.

It can cause significant, though often reversible, kidney impairment, and in more severe cases can contribute to acute kidney injury requiring closer monitoring or dose adjustment.

Yes, careful dosing based on kidney function and body weight, monitoring drug levels, ensuring adequate hydration, and limiting treatment duration where possible all help reduce risk.

Treatment involves stopping or adjusting the causative antibiotic where clinically possible, ensuring adequate hydration, and monitoring kidney function closely until it stabilises or improves.

Kidney function often improves within one to three weeks after stopping the causative drug, though recovery time can vary depending on the severity of damage and any other contributing factors.

Aminoglycosides specifically damage the kidney tubules through direct toxic accumulation, distinct from other drug-related kidney injuries that might work through reduced blood flow or allergic mechanisms, which is why monitoring drug levels specifically matters for aminoglycosides.

Those with pre-existing kidney impairment, older adults, people who are dehydrated, and those receiving prolonged or high-dose treatment are at higher risk and typically need closer monitoring.

This is typically identified and monitored by your treating medical team during antibiotic treatment through regular blood tests; report any concerns about reduced urine output or feeling unwell promptly to your treating team.